Diskussionsleitung: A. Ebert (Göttingen), S. Wagner (Regensburg)
| (P2217) | Development of CaMKII-HDAC4 protein-protein interaction inhibitors to treat heart disease | |
| M. Dewenter, A. von der Lieth, T. He, L. Chen, B. Grun, J. Eickhoff, M. van den Hoogenhof, J. Beckendorf, M. Hiltmann, G. Zischinsky, J. Tyedmers, S. Kumar Doddi, J. Lewis, M. Tiburcy, M. Hrabe de Angelis, W.-H. Zimmermann, B. Klebl, J. Backs (Heidelberg, Dortmund, Göttingen, München) | ||
| (P2218) | AAV1.SERCA2a mitigates heart failure in DMD pigs | |
| A. Bähr, N. Hornaschewitz, M. Stirm, P. Hoppmann, T. Bozoglu, K.-L. Laugwitz, N. Klymiuk, E. Wolf, R. J. Hajjar, C. Kupatt (München, Oberschleissheim; Cambridge MA, US) | ||
| (P2219) | Electrophysiological effects of dexamethasone on human ventricular cardiomyocytes | |
| B. Pfeilschifter, D. Fiegle, A. Ritzer, S. Sommer, V. Baron, C. Heim, M. Weyand, H. Milting, T. Seidel, T. Volk (Erlangen, Bad Oeynhausen) | ||
| (P2220) | Effects environmental factors on hERG channel current and gating kinetics in hiPSC-CMs from a patient with short QT syndrome | |
| X. Li, Z. Meng, C. Yan, Y. Lei, M. Li, X. Fan, L. Cyganek, I. El-Battrawy, X. Zhou, T. Wieland, I. Akin (Mannheim, Göttingen, Bochum) | ||
| (P2221) | Effects of gene mutation (N588K) on gating kinetics of hERG channel in hiPSC-CMs from a patient with short QT syndrome | |
| X. Li, Z. Meng, C. Yan, X. Fan, Y. Lei, M. Li, L. Cyganek, I. El-Battrawy, X. Zhou, T. Wieland, I. Akin (Mannheim, Göttingen, Bochum) | ||
| (P2222) | Reducing the number of experimental animals by cold storage of hearts prior to cardiomyocyte isolation | |
| B. Pfeilschifter, P. Potue, D. Fiegle, T. Volk, T. Seidel (Erlangen) |